CymaBay maps out regulatory filing for primary biliary cholangitis drug seladelpar

Regulatory applications in EU and the UK will follow a potential filing in the US in early 2024.

Sep 21, 2023 - 20:00

CymaBay maps out regulatory filing for primary biliary cholangitis drug seladelpar

Regulatory applications in EU and the UK will follow a potential filing in the US in early 2024.

Read the original article

Tags:

Previous Article

Evaxion partners with Afrigen Biologics to develop mRNA gonorrhea vaccine

GSK’s Ojjaara receives FDA approval for treating myelofibrosis patients with ana...

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Chiesi Farmaceutici gets grant for pharmaceutical formu...

Apr 5, 2024

Novavax is on thin ice, and the latest update isn’t exactly encouraging

Novavax is on thin ice, and the latest update isn’t exa...

Feb 1, 2024

AstraZeneca’s Truqap and Faslodex combo receives approval in EU

AstraZeneca’s Truqap and Faslodex combo receives approv...

Jun 22, 2024